Macter International Limited (PSX:MACTER)

Market Cap	15.39B
Revenue (ttm)	10.96B
Net Income (ttm)	834.71M
Shares Out	45.81M
EPS (ttm)	18.22
PE Ratio	18.45
Forward PE	n/a
Dividend	3.80 (1.13%)
Ex-Dividend Date	Oct 16, 2025

Volume	11,144
Average Volume	20,947
Open	338.86
Previous Close	337.59
Day's Range	335.37 - 339.80
52-Week Range	248.00 - 621.82
Beta	0.09
RSI	40.54
Earnings Date	Feb 17, 2026

About Macter International

Macter International Limited, a contract manufacturer, manufactures and markets pharmaceutical products and formulations for healthcare companies in Pakistan. It offers Upacnet, Indyco M, Digebro Syrup, and SEGLUTIDE. The company provides pharmaceutical products in the areas of antibiotics, anti-allergy, cardiovascular, anti-viral, etc.; and consumer and biological products. It also offers solid and liquid oral dosage forms, such as tablets, capsules, syrups, suspensions, and dry powders. In addition, the company provides injections, including ...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1992
• Employees: 1,282
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: MACTER

Financial Performance

In 2025, Macter International's revenue was 10.36 billion, an increase of 29.91% compared to the previous year's 7.97 billion. Earnings were 776.43 million, an increase of 90.91%.